What does Aier Ophthalmology’s successful fixed increase against the trend indicate?

A few days ago, Aier Ophthalmology successfully carried out refinancing under the contrarian trend. From a higher level, this is not only a major move of Aier Eye Hospital Group, but also reflects the common trend of non-public medical care to a certain extent.

In short, at least three big problems are illustrated.

One is: steadfast! Non-public medical care develops with confidence

Since the middle of last year, the stock market has continued to weaken, the market’s immunity has declined, and investors have become overly sensitive. For some rumors and speculations, whether they are justified or not, they would rather believe it or not, and listen to the wind and the rain. The shadow of the cup, the bow and the snake, the sound of the wind, and the shaking of the butterfly’s wings can also set off a big wave.

A typical performance is that the listed hospitals on March 15 fluctuated sharply due to unwarranted “conjectures”, which turned out to be false alarms afterwards. The successful refinancing of Aier Ophthalmology and the successive IPOs of listed hospital companies have undoubtedly reassured investors: to meet the diverse and multi-level medical needs of the masses, the state’s policy of supporting the development of non-public medical care has never changed!

For related content, please refer to the policy review of Aier Ophthalmology’s annual and interim reports over the years.

The second is: sure! Non-public medical care must be developed in a standardized way

This is the third refinancing of Aier Ophthalmology since its listing, which plays an important role in guaranteeing the company’s implementation of the new ten-year strategic plan. During this period, the company passed the “four security checks” supervised by intermediaries, exchanges, the China Securities Regulatory Commission and the media, and the company fully disclosed relevant issues.

Real gold is not afraid of fire. All types of hospitals should be aware that standardization and development are equally important! Only standardized development can be high-quality development and sustainable development. In fact, norms are both internal rigid requirements and external competitive advantages. For patients, the quality of medical care and service must be excellent; for investors, compliance operation and transparent norms must be excellent. Aier Ophthalmology Information Disclosure has been rated A for many consecutive years, which is also the result of adherence to standardization and rigidity.

The third is: Come on! Non-public medical care should be developed at a high level

Self-improvement is self-confidence! In recent years, both the number of hospitals and the number of visits, non-public medical care has made significant progress. Some specialized hospitals, including ophthalmology, have emerged a number of newcomers, and the brand reputation has a considerable influence.

However, compared with the growing needs of the people, there is still a big gap; compared with the goal of continuous improvement, long-term and arduous efforts are still required. Walking with the spirit of rushing for the exam at the foot, with an empty cup mentality in the chest, is the way to Huashan to continue to break through and continue to rise to the next level.

This refinancing of Aier Ophthalmology will be used to further improve the level of leading flagship hospitals, expand experts, and expand space, so that the majority of patients can see their diseases well, comfortably and with confidence. The goal is to become the terminal for difficult eye diseases. The leader in medical technology, and the active participation of many well-known institutions at home and abroad in the subscription, is not only the recognition of the company’s high certainty in the future, but also the recognition of the company’s pursuit of high-level development.

Of course, the above three points apply not only to Aier Ophthalmology, but also to any industry and enterprise that regulates development, strives for the top, and meets the needs of the public.

$Aier Ophthalmology(SZ300015)$ $Tencent Holdings(00700)$ $Kweichow Moutai(SH600519)$

This topic has 7 discussions in Snowball, click to view.
Snowball is an investor’s social network, and smart investors are here.
Click to download Snowball mobile client http://xueqiu.com/xz ]]>

This article is reproduced from: http://xueqiu.com/1463938984/232253587
This site is for inclusion only, and the copyright belongs to the original author.